Safety and Efficacy of EUS-RFA in Pancreatic Insulinoma
ConditionInsulinoma; Pancreas
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age15-80
SponsorSahlgrenska University Hospital
About this trial
Transcutaneous and EUS-guided radiofrequency ablation are both modern modalities to apply in the managemnet of various malignancies.
In the current study the investigators aim to study the technical feasibility, patient safety and clinical efficacy of EUS-RFA for the treatment of pancreatic insulinoma.
Eligibility criteria
Qualifiers
Insulinoma verified by pathology (often from EUS-FNB-sampling)
Disqualifiers
Patients unwilling to participate
Patients unable to understand and obtain written informed conscent
Severe comorbidity
Trial design
Treatments tested in this trial
- EUS-RFA
Treatment groups
20 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov